Roser Rovira-Alba
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The IL-6 axis in vascular inflammation: effects of IL-6 receptor blockade on vascular lesions from patients with giant-cell arteritis.
Journal: Annals of the rheumatic diseases
Published: February 06, 2025
Current evidence on the role of fibroblasts in large-vessel vasculitides: From pathogenesis to therapeutics.
Journal: Autoimmunity reviews
Published: March 11, 2024
Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis.
Journal: Journal of autoimmunity
Published: August 31, 2023
Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis.
Journal: Frontiers in immunology
Published: January 04, 2023
Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis.
Journal: Annals of the rheumatic diseases
Published: May 27, 2021
B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling: A Complementary Approach To Disrupt Pathological Vessels?
Journal: Circulation research
Published: June 13, 2020
Biological treatments in giant cell arteritis & Takayasu arteritis.
Journal: European journal of internal medicine
Published: October 24, 2017
Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy.
Journal: Scientific reports
Published: September 04, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026